PD-1 blockadePD-1 immunotherapyαPD-1 immunotherapynivolumabUniversity of California Irvineadvanced melanomaipilimumabChao Family Comprehensive Cancer CentermelanomaMelanoma-intrinsic+1 more
…Background Only 23% of advanced melanoma patients treated with PD-1 blockade have a ten-year progression free survival, 1 and it remains unk…